AstraZeneca prices $3bn bond offering

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Drugmaker AstraZeneca said it had priced its bond offering totalling $3bn.

The three-tranched bond offering, expected to close on 6 August 2020, included $1.2bn of fixed-rate notes with a coupon of 0.700%, maturing 8 April 2026; $1.3bn of fixed-rate notes with a coupon of 1.375%, maturing 6 August 2030; and $0.5bn of fixed-rate notes with a coupon of 2.125%, maturing 6 August 2050.

AstraZeneca said it expected to use the net proceeds of the issue for general corporate purposes.